It is important to clarify that our modified HScore for POP1 did not include hemophagocytosis and therefore yielded lower than expected mean scores for both our COVID-19 patients (132.8±40.1) and HLH patients (190.5±46.8). The gene discussed is POP1; the disease is Hemophagocytosis.